DEVANTHINIC PHARMA
0506.893.294 · rovalta.com · 08/11/2026
DEVANTHINIC PHARMA
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODEVANTHINIC PHARMA is a Private limited company incorporated in 2014. Its main activity is: Activities of holding companies. Its registered office is in Seneffe. It employs on average 8,4 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0506.893.294
- Incorporation
- 16/12/2014
- Legal form
- Private limited company
- Registered office
- Rue des Canadiens 24
7180 Seneffe · WallonieSee on map - Contributed capital
- 150 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 8,4 ETP
Joint committees (3)
- 121
- 200
- 313
Financials
Source · NBB, 11 filingsTrend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,3 M € | -5.5% | 1,4 M € | +13.3% | 1,2 M € | +2.0% | 1,2 M € | +29.9% | 930,2 k € |
| EBITDA | 887,9 k € | -13.7% | 1 M € | +8.6% | 947,7 k € | -2.7% | 973,5 k € | +12.9% | 862,1 k € |
| Operating result | 703,7 k € | -14.1% | 818,9 k € | -13.2% | 943,3 k € | -2.8% | 970,8 k € | +14.6% | 847,2 k € |
| Net result | 888,6 k € | -9.6% | 983,2 k € | +53.2% | 642 k € | -63.4% | 1,8 M € | +113% | 825,1 k € |
| Balance sheet | |||||||||
| Equity | 7,7 M € | +13.0% | 6,8 M € | +16.8% | 5,9 M € | +12.3% | 5,2 M € | +50.7% | 3,5 M € |
| Total assets | 16,8 M € | +0.8% | 16,7 M € | +6.9% | 15,6 M € | +8.5% | 14,4 M € | +3.0% | 14 M € |
| Cash | 351,4 k € | -24.0% | 462,4 k € | +117% | 213,3 k € | -46.8% | 401,3 k € | +40.5% | 285,6 k € |
| Debts | 8,7 M € | -9.7% | 9,6 M € | -1.2% | 9,8 M € | +6.3% | 9,2 M € | -12.7% | 10,5 M € |
| Other | |||||||||
| Workforce | 8,4 ETP | +25.4% | 6,7 ETP | +11.7% | 6,0 ETP | +22.4% | 4,9 ETP | +277% | 1,3 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
ANNE ANDRE | Directorsince 18/12/2014Manager18/12/2014 → 2019 accountsended |
Other companies at this address
Rue des Canadiens 24 7180 Seneffe| Company | CBE no. |
|---|---|
DEVANTHINIC IMMO● Active | 1039.753.688 |
MARIEC.C-PHARMA● Active | 0507.640.788 |
PHAMALIMO● Active | 0846.675.386 |
PHARMACIE ANNE ANDRE● Active | 0478.484.667 |
PHARMACIE DE BASCOUP● Active | 0458.492.472 |
PHARMACIE DE BOIS-D'HAINE● Active | 0432.058.190 |
PHARMACIE DE LA DRÊVE● Active | 0421.582.883 |
PHARMACIE DE LA GRAND RUE● Active | 0846.815.047 |
PHARMACIE DE LA VILLE BASSE● Active | 0872.063.652 |
PHARMACIE SENEFFE CENTRE● Active | 0477.710.053 |
PHARMA-LOUVE● Active | 0894.160.549 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/08/2026 | 29/08/2025 | 26/08/2024 | 31/07/2023 | 26/08/2022 | 30/08/2021 |
| General meeting | 31/07/2026 | 31/07/2025 | 31/07/2024 | 30/06/2023 | 26/05/2022 | 27/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 31/07/2026 | 27/08/2026 | French | |
| Abridged model | 31/12/2024 | 31/07/2025 | 29/08/2025 | French | |
| Abridged model | 31/12/2023 | 31/07/2024 | 26/08/2024 | French | |
| Abridged model | 31/12/2022 | 30/06/2023 | 31/07/2023 | French | |
| Abridged model | 31/12/2021 | 26/05/2022 | 26/08/2022 | French | |
| Abridged model | 31/12/2020 | 27/05/2021 | 30/08/2021 | French | |
| Micro model | 31/12/2019 | 28/05/2020 | 26/10/2020 | French | |
| Micro model | 31/12/2018 | 31/05/2019 | 09/09/2019 | French | |
| Micro model | 31/12/2017 | 31/05/2018 | 02/08/2018 | French | |
| Abridged model | 31/12/2016 | 26/05/2017 | 08/08/2017 | French | |
| Abridged model | 31/12/2015 | 26/05/2016 | 17/08/2016 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
ANNE ANDRE | Directorsince 18/12/2014Manager18/12/2014 → 2019 accountsended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other29/11/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
- Restructuring27/07/2018CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring16/05/2018RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates27/10/2017DEMISSIONS, NOMINATIONS
- Other21/02/2017DIVERS
- Mandates07/02/2017DEMISSIONS, NOMINATIONS
- Mandates08/04/2015DEMISSIONS, NOMINATIONS
- Other18/12/2014RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue des Canadiens 24, 7180 SeneffeCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00479392 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DEVANTHINIC PHARMACurrent | CBE | |
| DEVANTHINIC | accounts 2023 → 2025 | Accounts 2025 · 2026-00479392 |
| Devanthinic Pharma | accounts 2021 → 2022 | Accounts 2022 · 2023-00314109 |
Events
- 2025Annual accounts 2025888,6 k €↓
- 2024Annual accounts 2024983,2 k €↑
- 2023Annual accounts 2023642 k €↓
- 2023Name changeDEVANTHINIC
- 2022Annual accounts 20221,8 M €↑
- 2021Annual accounts 2021825,1 k €↑
- 2020Annual accounts 2020691,5 k €↑
- 2019Annual accounts 2019407,3 k €↓
- 2018Annual accounts 20181,3 M €↑
- 2017Annual accounts 201767,1 k €↑
- 2016Annual accounts 201641,7 k €↑
- 2015Annual accounts 201515,7 k €
- 16/12/2014IncorporationPrivate limited company